Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

dc.contributor.authorTasci, Elif Senocak
dc.contributor.authorOyan, Basak
dc.contributor.authorSonmez, Ozlem
dc.contributor.authorMutlu, Arda Ulas
dc.contributor.authorAtci, Muhammed Mustafa
dc.contributor.authorOner, Irem
dc.contributor.authorCinkir, Havva Yesil
dc.date.accessioned2024-02-23T14:31:12Z
dc.date.available2024-02-23T14:31:12Z
dc.date.issued2022
dc.departmentNEÜen_US
dc.descriptionASCO Gastrointestinal Cancers Symposium -- JAN 20-22, 2022 -- San Francisco, CAen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.doi10.1200/JCO.2022.40.4_suppl.202
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue4en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1200/JCO.2022.40.4_suppl.202
dc.identifier.urihttps://hdl.handle.net/20.500.12452/15089
dc.identifier.volume40en_US
dc.identifier.wosWOS:000770995900198en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofJournal Of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleEfficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group studyen_US
dc.typeConference Objecten_US

Dosyalar